Liquid biopsy-based epigenetic signatures for early detection of prostate cancer: a systematic review.

Cleanclay WD, Kintung IF, Kernyuy FB, Yensii NG, Fagbohun BO, Amadi EC, Kaze NN

Open source

DOI
10.3389/fonc.2026.1800705
Published
2026
Container
Frontiers in oncology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2026.1800705,
  title = {Liquid biopsy-based epigenetic signatures for early detection of prostate cancer: a systematic review.},
  author = {Cleanclay WD and Kintung IF and Kernyuy FB and Yensii NG and Fagbohun BO and Amadi EC and Kaze NN},
  year = {2026},
  journal = {Frontiers in oncology},
  doi = {10.3389/fonc.2026.1800705},
  url = {https://doi.org/10.3389/fonc.2026.1800705}
}

RIS

TY  - JOUR
TI  - Liquid biopsy-based epigenetic signatures for early detection of prostate cancer: a systematic review.
AU  - Cleanclay WD
AU  - Kintung IF
AU  - Kernyuy FB
AU  - Yensii NG
AU  - Fagbohun BO
AU  - Amadi EC
AU  - Kaze NN
PY  - 2026
JO  - Frontiers in oncology
DO  - 10.3389/fonc.2026.1800705
UR  - https://doi.org/10.3389/fonc.2026.1800705
ER  - 

APA

WD, C., IF, K., FB, K., NG, Y., BO, F., EC, A., & NN, K. (2026). Liquid biopsy-based epigenetic signatures for early detection of prostate cancer: a systematic review.. Frontiers in oncology. https://doi.org/10.3389/fonc.2026.1800705

Source records